US1011371077
US1011371077
Boston Scientific Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 61.93B EUR | 62.75B EUR | 93.26B EUR | 141.4B EUR |
Enterprise Value | 73.25B EUR | 62.75B EUR | 102.84B EUR | 150.88B EUR |
Valuation Multiples | ||||
Trailing P/E | 17.3x | 22.67x | 26.16x | 48.79x |
Forward P/E | 12.65x | -- | -- | -- |
Price to Sales | 2.95x | 4.03x | 4.52x | 7.04x |
Price to Book | 2.48x | -- | 3.61x | 5.84x |
EV/Revenue | 3.49x | 4.03x | 4.99x | 7.52x |
EV/EBITDA | 12.83x | 14.97x | 18.1x | 28.29x |
Price to FCF (P/FCF) | 25.26x | 27.8x | 28.28x | 41.54x |
EV/FCF | 29.88x | 27.8x | 31.18x | 44.32x |
FCF Yield | 3.96% | 3.6% | 3.54% | 2.41% |